CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Open-market sale Pres. Diagnostics & Genom sold 500 shares at an average $505.38 ($252,689)
- 4 Open-market sale President-Protein Sciences sold 27,159 shares at an average $504.00 ($13,688,193)
- 4 Open-market sale Chief Financial Officer sold 9,022 shares at an average $526.49 ($4,749,990)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 762 shares at an average $525.23 ($400,222)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Open-market sale Pres. Diagnostics & Genom sold 822 shares at $529.04 ($434,871)
- 4 Open-market sale Director sold 8,000 shares at an average $509.98 ($4,079,823)
- 4 Shares withheld for taxes Chief Executive Officer gave up 42,005 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $507.22 ($5,072,165)
- 4 Open-market sale SVP - General Counsel sold 6,871 shares at an average $509.94 ($3,503,764)
- 4 Open-market sale President-Protein Sciences sold 1,538 shares at $503.07 ($773,728)
- 4 Open-market sale SVP - General Counsel sold 5,000 shares at an average $505.66 ($2,528,311)
- 4 Open-market sale Director sold 4,000 shares at $481.52 ($1,926,065)
Page 10 of 35 · 695 filings